Goldman Sachs’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.38M Buy
339,196
+262,319
+341% +$5.71M ﹤0.01% 2500
2025
Q1
$1.42M Sell
76,877
-130,392
-63% -$2.41M ﹤0.01% 3583
2024
Q4
$5.52M Buy
207,269
+134,301
+184% +$3.58M ﹤0.01% 2781
2024
Q3
$1.71M Buy
+72,968
New +$1.71M ﹤0.01% 3468